Searched for
ARJUN SHANKER BHARTIA
Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...09 Dec, 2022, 12.54 PM IST- Buy Jubilant Ingrevia, target price Rs 860: Prabhudas LilladherFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1175.90 crore, down 9.89 per cent from last...07 Sep, 2022, 01.09 PM IST
- Buy Jubilant Life Sciences, price target Rs 580: Kunal BothraThe analyst suggested a stoploss at Rs 537 .04 Feb, 2020, 11.43 AM IST
- Buy Jubilant Life Sciences, price target Rs 575: Kunal BothraThe analyst suggested a stoploss at Rs 533.17 Dec, 2019, 11.40 AM IST
- Neutral Jubilant Life Sciences, target Rs 905: Motilal Oswal SecuritiesMotilal Oswal Securities is neutral Jubilant Life Sciences at a price target of Rs 905. The time period given to achieve the target is a qu...19 Jul, 2017, 08.39 AM IST
- Jubilant Life appoints Priyavrat Bhartia, Arjun Shanker as directorsPriyavrat Bhartia is the son of Chairman Shyam S Bhartia while Arjun Shanker Bhartia is the son of co-Chairman and Managing Director Hari S...24 May, 2017, 06.35 PM IST
Load More
